BRCA-1 and BRCA-2
Article Sources
NOTE: This article is based on research that utilizes the sources cited here as well as the collective experience of the Lab Tests Online Editorial Review Board. This article is periodically reviewed by the Editorial Board and may be updated as a result of the review. Any new sources cited will be added to the list and distinguished from the original sources used.
S1
Fasouliotis SJ and Schenker JG. BRCA1 and BRCA2 Gene Mutations: Decision-Making Dilemmas Concerning Testing and Management. Obstetrical and Gynecological Survey 55(6); 373-384 (2000).
Sources Used in November 2005 Update
S2
(2005 September 16, Revised). Overview: Breast Cancer [30 paragraphs of Overview]. American Cancer Society [On-line information]. Available FTP: http://www.cancer.org/docroot/CRI/CRI_2_1x.asp?rnav=criov&dt=5
S3
(2005 January 1, Revised). Overview: Ovarian Cancer [12 paragraphs of Overview]. American Cancer Society [On-line information]. Available FTP: http://www.cancer.org/docroot/CRI/CRI_2_1x.asp?dt=33
S4
(2005 September 5). Task Force Recommends Against Routine Testing for Genetic Risk of Breast or Ovarian Cancer in the General Population [11 paragraphs]. Agency for Healthcare Research and Quality [On-line Press Release]. Available FTP: http://www.ahrq.gov/news/press/pr2005/brcagenpr.htm
S5
(2005 July 18, Updated). Fact Sheet on Genetic Testing for Breast and Ovarian Cancer Susceptibility [31 paragraphs]. CDC Genomics and Disease Prevention [On-line information]. Available FTP: http://www.cdc.gov/genomics/info/factshts/breastcancer.htm
S6
(2005 September). Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility [6 paragraphs]. U.S. Preventive Services Task Force [On-line Press Release]. Available FTP:
http://www.ahrq.gov/clinic/uspstf/uspsbrgen.htm
S7
Petrucelli, N. et. al. (2004 September 3). BRCA1 and BRCA2 Hereditary Breast/Ovarian Cancer]. GeneReviews [On-line information]. Available online
S8
Brown, A. (2005 September 23). Most Breast Cancers Not Linked to Ovarian Cancer [7 paragraphs]. MedlinePlus Reuters Health Information, from Journal of the National Cancer Institute [On-line information]. Available FTP: http://www.nlm.nih.gov/medlineplus/news/fullstory_27070.html
S9
Brian E Ward, Ph.D. FACMG
Senior Vice President of Medical Services
Myriad Genetic Laboratories





